Valneva SE VALN
NASDAQ VALN
$6.95 -0.11 (-1.63%)
As of: Sep 4, 2026 · 12:37 PM EDT

Valneva SE (VALN) EBITDA (2021 - 2026)

Valneva SE (VALN) posted EBITDA of -$21.3 million for Q1 2026, up 15.65% sequentially from -$25.3 million in Q4 2025, and down 3276.1% YoY from $670873.2 in Q1 2025.

Analysis

Valneva SE (VALN) EBITDA (2021 - 2026) Analysis & Trends

Valneva SE has reported EBITDA for 6 years, with the latest figure at -$21.3 million in Q1 2026.

  • Quarterly EBITDA fell 3276.1% year-over-year to -$21.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$89.7 million (down 104.67% YoY) and the FY2025 annual result came in at -$69.1 million, down 294.18% from the prior year.
  • EBITDA rose to -$21.3 million in Q1 2026 per VALN's latest filing, from -$25.3 million in the prior quarter.
  • Over five years, EBITDA peaked at $38.7 billion in Q4 2022 and troughed at -$38.1 billion in Q3 2022.
  • A 5-year average of $14.7 million and a median of -$18.1 million in 2024 frame the typical range for EBITDA.
  • The widest YoY moves for EBITDA: up 19080.79% in 2022, down 21259.55% in 2022.
  • Over 5 years, EBITDA stood at $38.7 billion in 2022, then slumped by 100.05% to -$20.7 million in 2023, then increased by 18.79% to -$16.8 million in 2024, then slumped by 50.56% to -$25.3 million in 2025, then increased by 15.65% to -$21.3 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$21.3 million, -$25.3 million, and -$37.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.72 Bn 77.72 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.56 Bn 58.38 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.87 Bn 52.73 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn - -505.13 Mn
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.20 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.54 Bn 27.70 Bn - 133.12 Mn
9 Insmed 27.49 Bn 26.33 Bn 358.27 Mn -1.55 Mn
10 Valneva SE 584.00 Mn 442.75 Mn 1.86 Mn -25.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.46 Mn
Mar 31, 2026 -21.31 Mn
Dec 31, 2025 -25.26 Mn
Sep 30, 2025 -37.06 Mn
Jun 30, 2025 -6.11 Mn
Mar 31, 2025 -631,130.66
Dec 31, 2024 -16.78 Mn
Sep 30, 2024 -8.30 Mn
Jun 30, 2024 -18.14 Mn
Mar 31, 2024 79.30 Mn
Dec 31, 2023 -20.66 Mn
Sep 30, 2023 -19.27 Mn
Jun 30, 2023 -17.42 Mn
Mar 31, 2023 -13.20 Mn
Dec 31, 2022 38.67 Bn
Sep 30, 2022 -38.14 Bn
Jun 30, 2022 -130.93 Mn
Mar 31, 2022 -14.93 Mn
Dec 31, 2021 201.58 Mn
Sep 30, 2021 -178.58 Mn